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The investigation of the microbial populations of the human body, known as the
microbiome, has led to a revolutionary field of science, and understanding of its
impacts on human development and health. The majority of microbiome research to
date has focussed on bacteria and other kingdoms of life, such as fungi. Trailing behind
these is the interrogation of the gut viruses, specifically the phageome. Bacteriophages,
viruses that infect bacterial hosts, are known to dictate the dynamics and diversity of
bacterial populations in a number of ecosystems. However, the phageome of the human
gut, while of apparent importance, remains an area of many unknowns. In this paper we
discuss the role of bacteriophages within the human gut microbiome. We examine the
methods used to study bacteriophage populations, how this evolved over time and what
we now understand about the phageome. We review the phageome development in
infancy, and factors that may influence phage populations in adult life. The role and action
of the phageome is then discussed at both a biological-level, and in the broader context of
human health and disease.
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In the past decade, the importance of the human gut microbiome in both health and disease has
come to light. It plays a role in the acquisition of nutrients, defence, and in a range of diseases, from
gastrointestinal to neurological. Most of these microbiome studies focus solely on bacterial
populations, with fungal, archaeal and viral communities often being neglected. However, it is of
vital importance that the viruses of microbes, particularly bacteriophage populations, are not
overlooked. These bacteriophages (phages), viruses that solely infect bacteria, are the most
numerous viral component within the human body (Reyes et al., 2010; Minot et al., 2011), and
are predicted to play a significant role in the maintenance of human health, through processes such
as horizontal gene transfer (Camarillo-Guerrero et al., 2021).
Phages were first discovered in the early 1900’s simultaneously by d’Hérelle and Twort. At the
time they were recognised as an alternative to antibiotic therapy (d’Herelle, 1918; d’Herelle, 1919;gy | www.frontiersin.org June 2021 | Volume 11 | Article 6432141
Townsend et al. Gut Phageome: Origins and RolesTwort, 1961), but faded into obscurity in Western medicine,
before returning as a tool to improve human health in the face of
the current antibiotic resistance crisis (Kortright et al., 2019).
While the majority of research has focussed on utilizing
phages for therapeutic and biotechnology purposes, the field of
analysing natural phage communities in the gut is relatively
young and information on phages is often disregarded within
microbial metagenome and metatranscriptome libraries. In
order to effectively and safely administer phage therapy it is
vital to understand natural phage interactions within the human
microbiome. Typically, the investigation of the roles phages play
in ecosystems has largely focused on marine and terrestrial
environments, while the human body remains underexplored.
In part, this may be due to issues arising from ethics surrounding
samples of human origin and the difficulty of sampling the gut.
Bacteria are the most abundant cellular organisms in the gut.
The gut is a nutritionally rich environment which allows
bacterial concentrations of close to the theoretical maximum in
the order of 107 to 1014 cells, depending on the exact location
(Sender et al., 2016). Therefore, there are an abundance of hosts
available for phages to infect, which is of importance given the
vast majority of viruses within the gut are phages. Together, the
total community of phage populations is known as
the phageome.
In this review we will discuss what is known about: how
phages enter the body, how we study the phageome, its main
components, and the important roles and functions it performs
in both human health and disease.METHODS TO IDENTIFY AND
CHARACTERIZE PHAGES IN THE GUT
Since the early work of d’Hérelle (1921), many vital questions
within phage biology, and specifically the role in ecosystems such
as the human gut, remain unanswered. Techniques used for
identifying and characterizing phages in the human gut can
be understood from three perspectives: culture-dependent
methods, culture-independent methods, and sequencing-based
methods. Before the rise of next-generation sequencing in
the last 15 years, culture-based methods were the primary
approach for researching phage ecology, these rely on isolation
techniques to extract virions for investigation (Figure 1) (Mokili
et al., 2012).
Culture-Dependent Methods
For culture-based methods it is necessary to isolate virus-like
particles (VLPs) from their complex in situ environment. This is
often performed on faecal samples due to the ease and minimal
cost in obtaining them. However, the bacterial community of the
mucosa-associated microbiome is dominated by different phyla
to those found in faeces (Lepage et al., 2005), so much so that it is
compositionally distinct (Gillevet et al., 2010). Thus, sampling of
faeces may select a combination of shed mucosal bacteria and
nonadherent luminal populations (Eckburg et al., 2005). This
sampling effect is likely to also affect the phage communitiesFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2recovered. The relative understanding of phageome composition
from faecal sampling is visualised in Figure 2, which highlights
gaps in our knowledge from the acquisition of phages through
diet, to the various positions of the digestive system. We suggest
that future research efforts work towards a more holistic view of
the human gut phageome, which undoubtedly relies on
colonoscopies for the targeted sampling of the ileum and
colon. This will facilitate the study of the phage populations in
active luminal and mucosal-associated communities, in order to
describe compositional differences in the respective phageomes,
and to understand their possible in situ influence on the overall
gut microbiome and the human host health.
Three approaches are taken to isolate phages from
heterogeneous samples: extraction and purification of virus-like
particles (VLPs), enrichment of phages in bacterial host cultures,
and induction of temperate phages from lysogenised hosts.
Extraction and purification of VLPs is the most common
approach, which we describe below.
Following the suspension of faecal matter, intact VLPs can be
separated from other microorganisms and free DNA in the faecal
suspension by multiple methods, often used in combination
(Thurber et al., 2009; Castro-Mejia et al., 2015; Kleiner et al.,
2015). Conventional size-fractionation filtration to separate out
phages introduces bias against larger VLPs, highlighting the need
for novel methods (Serwer et al., 2009; Conceicao-Neto et al.,
2015). The efficacy of VLP enrichment can be validated with
staining and epifluorescence microscopy (see section Culture-
Independent Methods). Gut-dwelling phages can subsequently be
isolated using gut-specific bacterial strains to screen for infecting
phages within the VLP fraction.
Isolating phages that infect bacteria cultured from the same
environment has been readily applied to model hosts including
Escherichia coli and Bacteroides fragilis (Gantzer et al., 2002).
These can then be used to characterize aspects of phage-host
biology, such as phage virulence and persistence. Further,
isolation and cultivation is essential to characterize phage
replication strategies and understand phage gene function,
particularly given that we are limited in assigning functions to
~30% of phage genes (Silveira et al., 2020). While culture-based
methods prove useful in isolating candidates for therapeutic and
industrial applications (Bonilla et al., 2010; Mattila et al., 2015),
the isolation of gut phages for ecological purposes is limited by
host selection bias. In fact, it is challenging to culture gut
bacterial strains or obtain those already cultured, with many
sampling efforts focused on aerobic bacteria associated with
disease from a small percentage of the human population.
To overcome this issue, recent progression in the field of
culturomics (Lagier et al., 2012), which combines diversified
culturing conditions (Lagier et al., 2015) with mass spectrometry
(MALDI-TOF) and 16S rRNA sequencing, has helped to identify
much of this bacterial dark matter of the gut, once thought to be
uncultivable (Lagier et al., 2015). This technique has been used to
add many gut bacterial isolates to the repertoire for isolating gut
phages (Lagier et al., 2016). For example, the combination of
culturing, enrichment and sequencing techniques has led to the
discovery and isolation of the widespread human CrAssphageJune 2021 | Volume 11 | Article 643214
Townsend et al. Gut Phageome: Origins and RolesFIGURE 1 | Timeline of methodological discoveries. A summarised timeline including the invention of key tools for the study of phages, from their discovery in 1921
to recent modern metagenomic sequencing technologies. Adapted from Mokili et al. (2012).FIGURE 2 | Schematic of the human gut, indicating unknown inputs to the gut phageome from diet and the environment, highlighting the largely unknown phage
composition of the ileum and colon and indicating the relative proportions of phages in the best understood samples: faeces. Circle size provides a rough guide to
the relative abundance of phage particles observed in different gut compartments (Zoetendal et al., 2012; Hoyles et al., 2014; Shkoporov and Hill, 2019), but current
understanding is still lacking. Most research activity has focused on faecal samples, represented in the lowest pie chart, depicting the relative proportions of different
phage groups identified through metagenome analysis, based on Shkoporov and Hill (2019).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org June 2021 | Volume 11 | Article 6432143
Townsend et al. Gut Phageome: Origins and Roles(see section Identification of Novel Human Phages) (Dutilh et al.,
2014; Shkoporov et al., 2018a).
Temperate phages, integrated within their bacterial host
genomes as prophages, also pose a challenge for isolation, but
can be induced from lysogenised isolates using UV light (Furuse
et al., 1983), mitomycin C, and heat treatment (Pelzek et al.,
2013). Induced prophages can then be separated from their hosts
using the same methods as for virulent phages. Non-lysogenised
reporter host strains can then be used to verify temperate phage
infectivity. There is debate over the relative importance of
virulent and temperate phages in the gut (see section Phage-
Host Population Dynamics), therefore the isolation of a range of
phages with different replication strategies is key to testing
these hypotheses.
In addition to characterizing aspects of phage-host
interactions, concentrated phage populations can be further
interrogated with flow cytometry (Brown et al., 2015),
microscopy and molecular biology techniques (Castro-Mejia
et al., 2015) (see section Culture-Independent Methods), or
sequenced for further in silico analyses (see section
Metagenomics). Culture-dependent methods of phage isolation
and characterisation focus on individual phage functions and
replication strategies. Despite this being vital for the investigation
of phage populations and phage-host dynamics, culture-
independent methods have facilitated the study of phageome
diversity and function.
Culture-Independent Methods
While the recent rise in culture-independent methods since the
1980s was due to the advent of Sanger sequencing, these methods
arose decades earlier thanks to electron microscopy (EM)Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4(Figure 1). Phages were first visualised with EM in the 1930s
(Peankuch and Kausche, 1940; Ruska, 1940), which
circumvented the magnification limitations of light
microscopes, allowing for the visualisation of phages.
Transmission EM (TEM) was used to observe that tailed
phages were the most abundant VLPs in human faeces
(Flewett et al., 1974), with recent microscopy indicating that
the gut virome is almost exclusively represented by the order
Caudovirales (Hoyles et al., 2014; Guerin et al., 2018). A large
diversity of viral morphotypes have been visualised within
individuals (Hoyles et al., 2014), with most VLPs representing
phages. Microscopic techniques have also been used to
enumerate gut phages (Lepage et al., 2008; Hoyles et al., 2014),
however it has been suggested that TEM and staining could
overestimate the true active phageome by up to 8 times (Kleiner
et al., 2015). An evaluation of the staining and visualisation
techniques that have led to a number of important discoveries is
given in Table 1. The revelation of the high abundance of viruses,
especially phages, in the human gut as observed by microscopy
has paved the way for modern phage research.
Modern molecular biology techniques reflect the biochemical,
technological and high throughput advancements made over the
past few decades. The use of which have resulted in
breakthroughs such as the identification of toxin-antitoxin
systems in Lactobacil lus johnsonii prophages using
recombinant protein gene expression (Denou et al., 2008). The
use of molecular biology for gut phage research is evaluated in
Table 2.
It is finally worth noting the use of whole animal models for
investigating the factors that drive microbiome structure and
function, and disease-state modelling of the human gut,TABLE 1 | Microscopy techniques used to study the gut phageome, including the major advantages and limitations of each technique.
Technique Example gut discoveries Advantages Limitations
TEM Tailed phages were the most abundant VLPs in human
faeces (Flewett et al., 1974).
Visualisation of phage morphology. Biased towards identifying tailed phages due
to potential loss of tail structures in sample
preparation (Williamson et al., 2008).
Faecal samples from patients were found to share no
VLPs (Hoyles et al., 2014).
Limited to observations of morphologies.
Time-consuming.
EFM Up to 5.58 x 109 VLPs were observed per gram of faeces
(Hoyles et al., 2014).
Enumeration of VLPs in samples. VLP counts are conservative estimates of
true viral abundances, given the imprecision
of visualising single fluorescent dots.
Can validate viral purification procedures. Loss of VLPs during preparation and
filtration of samples, e.g. large VLPs of the
order Megavirales (Colson et al., 2010).
Greater accuracy and speed compared to TEM. Viability of the VLP to infect and lyse
bacterial cells is unknown.
VLPs may be membrane vesicles, gene
transfer agents or cell debris containing
nucleic acids (Forterre et al., 2013).
phageFISH The viability of VLPs can be determined through single
cell dynamic measurements, as shown with marine
phages (Allers et al., 2013).
PhageFISH is the only non-genetic method to
implicate lytic, lysogenic, and chronic phage
infection modes (Dang and Sullivan, 2014).
CLSM The complex microenvironment and spatiotemporal
succession can be studied in multispecies biofilms, as
shown with non-phage viruses (Røder et al., 2016).
Non-destructive sampling. Can be used to
visualise the biofilm infection over time.
Limited to biofilms of bacterial species which
can be fluorescently labelled.
CryoEM Phage capsids of Bortadella phages were visualised at
angstrom resolution, discovering unique protein folds, as
shown with non-gut phages (Zhang et al., 2013).
Very high resolution. Destructive sampling.June 2021 | Volume 11 | Article 643214
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Bacteriophages in Human Disease). Animal models enable the
experimental investigation of phage-host interactions, to develop
hypotheses that connect alterations in the gut microbiome to
disease. An extensive review of simple animal models of the gut
microbiome was written by Douglas (2019). Murine models have
been applied to a wide range of phage studies, including phage-
host population dynamics over time (Hsu et al., 2019), changes
in phage populations after antibiotic exposure (Modi et al.,
2013), investigating the role and function of phage proteins
(Miernikiewicz et al., 2016), and the abundance and activity of
prophages in the gut (Kim and Bae, 2018). However, there has
been much critique of the use of mice models to represent the
human gut, discussed in Nguyen et al. (2015). Animal models
have enabled hypothesis generation and testing, but due to
differences in their physiology and natural microbiota, they
should be used as a stepping-stone rather than as final
evidence to inform human microbiome related medicine.
Metagenomics
Metagenomics is the most recent development on the gut
phageome methods timeline, facilitated by the advent of high-
throughput sequencing (Figure 1). Metagenomics provides aFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5snapshot of the DNA phage community: the populations that
can be recovered, and the genes they encode. There are two
favoured approaches to performing metagenomics: sequencing
of the entire nucleic acid complement through shotgun
metagenomics, and amplification of marker genes such as the
16S ribosomal RNA gene in amplicon sequencing (Jovel et al.,
2016; Hayes et al., 2017). Given the absence of a universal viral
marker gene, amplicon approaches are unviable for studying the
phageome, although some group-specific markers do exist for
estimations of phage diversity (Adriaenssens and Cowan, 2014).
Instead, whole-community metagenome (WCM) sequencing has
been demonstrably the most successful method for exploring
phage communities across environmental niches (Hayes et al.,
2017). Metagenomic sequencing of gut microbiome free-phages
relies on enrichment of VLPs, prior to nucleic acid extraction,
introducing the previously discussed biases. Protocols typically
use size fractionation of free phages selecting for < 200 nm, with
particular focus on DNA phages (Kleiner et al., 2015). A review
of the steps involved in producing phage metagenomes,
including the biases associated with each step, has been
reviewed by Hayes et al. (2017).
The first use of viral metagenomics (viromics) on the human
gut described phages found in human faeces, finding evidence forTABLE 2 | Summary of molecular biology techniques used to study the gut phageome, including the major advantages and limitations of each technique.
Technique Example gut discoveries Advantages Limitations
Electrophoresis SDS-polyacrylamide gel electrophoresis on a CsCl
fraction of human faeces isolated CrAss-like
phages for subsequent mass spectrometry (Guerin
et al., 2018).
Multiple viral populations can be
separated from multispecies samples
due to their differing capsid sizes.





Toxin-antitoxin systems were identified within
prophages of Lactobacillus johnsonii (Denou et al.,
2008).
Proteins can be overexpressed to
obtain high titres for subsequent
analysis.
Cloning of viral genes into heterologous host systems can
be difficult given that viral genomes often encode modified
nucleotides (Warren, 1980) and lethal genes (Wang et al.,
2010).
Expressed proteins may not be functional due to
misfolding and incorrect modifications in expression host.
Microarrays The new-born infant gut viral community was
found to be dynamic (Breitbart et al., 2008).
High-throughput. Incompatible with novel viral genomes as a priori
sequence information is required to design probes.
50% of the strain-specific DNA in Lactobacillus
johnsonii was found to derive from prophages
(Ventura et al., 2003).
Viral DNA amplification steps prior to microarray analysis
can introduce bias, making relative abundances no longer




Sequencing of commensal gut bacteria can
facilitate the identification of integrated prophages
(Ventura et al., 2003; Denou et al., 2008).
Facilitates taxonomic investigation. Requires isolation and cultivation of lytic phages and hosts
of temperate phages.
Can assemble viral genomes for




qPCR 77% of faecal samples contained phages carrying
at least one antibiotic resistance gene (Quiros
et al., 2014).
Detection and quantification of
specific genes in real time.
Sequence of target gene is required a priori.
Longitudinal tracking of phage and bacterial hosts
in the faeces of a mouse model system facilitated
the study of predator-prey dynamics (Hsu et al.,
2019).




363 unique phage-host pairings were predicted,
including many uncharacterised phages (Džunková
et al., 2019).
Infer phage-host relationships. Direct evidence of successful phage infection is not
provided by attachment of phage and host cell.
Culture-independent. Different assay conditions can bias the phage-host
pairings observed from the community.Flow cytometry has the facility to sort
individual phage-host pairs for
downstream sequencing etc.June 2021 | Volume 11 | Article 643214
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then, many studies have aimed to identify phages from gut
WCMs (Ogilvie et al., 2013; Waller et al., 2014). While
metagenomes are expected to be dominated by bacterial DNA,
it has been shown that up to 17% of gut microbial DNA is
predicted to be of phage origin (Ogilvie et al., 2013). The phage
sequences recovered are likely to be predominantly prophages,
given the abundance of bacterial DNA in gut metagenomes
(Williamson et al., 2008; Stern et al., 2012). This is not a
limitation, as the gut phageome of humans and mice is
dominated by integrated prophages, carried by the majority of
intestinal bacteria (Waller et al., 2014; Kim and Bae, 2018).
Nonetheless, analysing both the viral metagenome (virome) and
WCMs from faecal samples is essential to appreciate the total
phage community occupying the gut niche. Furthermore, it is
particularly important for deciphering the presence of a core
gut phageome.
Phage populations recovered through viromics do not
necessarily reflect the true diversity of the gut phageome; larger
phage genomes are often only assembled for the most abundant
viral genotypes present within a sample, and many lowly
abundant viral species are likely to be lost in purification steps
during sample preparation or biased against by the sequencing
protocol. In addition, the phylogenetic binning strategy for
reconstructing short reads in shotgun metagenomes may result
in the loss of closely related phage contigs due to high nucleotideFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6sequence similarity. Genome assembly and binning is
complicated by mosaicism within phage genomes, a common
feature of prophages (Lima-Mendez et al., 2011), which are of
particular interest in the gut phageome (Waller et al., 2014; Kim
and Bae, 2018). Given this, and the costs associated with
achieving high sequencing depths from faecal samples, many
contigs represent only fragments of the true sequenced gut phage
genomes (Shkoporov and Hill, 2019). To mitigate issues with the
accuracy of viral population detection, the research community
has defined thresholds of contig length and read coverage to
balance sensitivity with false-discovery rate (Roux et al., 2017).
This includes considering phage populations as “detected” only
when virome reads map at ≥ 90% nucleotide identity to non-
redundant contigs ≥ 10 kb over ≥ 75% of their length.
Subsequent false-discovery rates have been shown to remain
low at 0.2% using these thresholds (Roux et al., 2017). Further,
software tools such as CheckV (Nayfach et al., 2020) can be
integrated into viromics pipelines to estimate the confidence in
assembled phage genomes for downstream analyses (Table 3). A
confidence score of > 90% completeness indicates high quality
contigs, important for distinguishing short contigs as near-
complete phage genomes. CheckV can also be used to identify
integrated prophages through the detection of flanking host
genes (Nayfach et al., 2020).
As a consequence of the above limitations, and the exclusion
of single-stranded DNA (ssDNA) and RNA phages whose trueTABLE 3 | Bioinformatic tools used to study the gut phageome, including techniques, research questions they may address and name of the software.




Do the phage genomes encode
auxiliary metabolic genes
(AMGs)?
Prodigal (Hyatt et al., 2010) or PHANOTATE (McNair et al., 2019) to predict coding sequences.
Do the phage genomes encode
viral taxon-specific genes?
Prokka (Seemann, 2014) or eggNOG (Powell et al., 2012), to functionally annotate draft
genomes.
Are the phages temperate or
virulent?
Hmmscan (Eddy, 2011), to align protein sequences to databases (e.g. pVOGs (Grazziotin et al.,
2016) and Pfam/vFam (Skewes-Cox et al., 2014; El-Gebali et al., 2019) and Genecatalog (Li
et al., 2014).
(Clooney et al., 2019)
Is there a global phage gene
pool?
Phyre2 (Kelley et al., 2015), to find proteins with structural homology .
DRAM-v to predict putative AMGs associated with metabolism (Shaffer et al., 2020).
Phage
prediction
Are the genomes assembled
phage genomes?
De-novo prediction of phages using tools such as VirFinder/ DeepVirFinder (Ren et al. 2017;
Ren et al., 2002) and VirSorter2 (Guo et al., 2021)
Confirmation of viral genome completeness with CheckV (Nayfach et al., 2020) and IMG/VR v3
(Roux et al., 2021).
How diverse are the phages? Alignment to hallmark taxon-specific marker genes. (Waller et al., 2014)
Are any known viral taxa
predicted?
BLAST (Camacho et al., 2009), PhymmBL (Brady and Salzberg, 2009) and k-mer approaches
(Trifonov and Rabadan, 2010), for taxonomic assignment.
(Vazquez-
Castellanos et al.,
2014)Comparison to gut viral databases, e.g. Gut Virome Database (GVD) (Gregory et al., 2020).
How similar are they to phages
in other ecosystems?
Single protein phylogenies with alignment of core phage genes, e.g. using MAFFT (Katoh and
Standley, 2013).
De-novo classification with vConTACT2 (Zablocki et al., 2019).
Phage-host
relationships
Which gut hosts do the phages
infect?
Genetic homology of integration sites and CRISPR spacer sequences between phage and host. (Stern et al., 2012)
Is phage predation species or
strain specific?
Phage genome signature-based recovery. (Ogilvie et al., 2013)
Identification of integrated prophage.
Abundance profiles. (Dutilh et al., 2014)
De-novo relationships with WIsH (Galiez et al., 2017)June 2021 | Volume 11 | Article 643214
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diversity through metagenomics often underestimates absolute
viral richness. Further, inferences on phage diversity yield only a
snapshot of the sampled phage community at a given time point.
The temporal dynamics of the gut microbiome can only be
understood by sampling multiple time points, which adds
logistical challenges of recalling participants, costs, and is both
more lab- and bioinformatically-intensive due to the size of the
datasets assembled and analysed. Nonetheless, there are a few
examples of longitudinal studies of the gut phageome, which are
discussed in section Development of the Phageome (Minot et al.,
2013; Shkoporov and Hill, 2019).
There are a number of tools used to describe and interrogate
environmental phageomes through metagenomics, reviewed in
Table 3. Many of these tools are alignment-based, requiring
sequence homology between genes and genomes for annotation,
phage classification and the inference of phage-host
relationships. Historically, due to the underrepresentation of
viruses in reference databases, in conjunction with a high
proportion of novel phages sequenced from the gut
(Shkoporov et al., 2018b), alignment-based approaches were
limited. It has been reported that > 75% of reads from gut
viromes did not align with known viral genomes (Aggarwala
et al., 2017). In another study, < 2% of the viral genomes
assembled from human faeces could be assigned to known taxa
(Shkoporov et al., 2018b). Additionally, both RNA (Callanan
et al., 2020) and non-tailed (Kauffman et al., 2018) phages are
significantly underrepresented in phage databases. Therefore,
alternative tools that do not rely on similarity to databases
have been proposed to circumvent these limitations (Reyes et
al., 2012), but have yet to see widespread implementation.
Recently, great advances have been made in assembling
comprehensive databases for the detection of viral populations
from gut microbiome studies, e.g. Gut Virome Database
(Gregory et al., 2020). A combination of this increased viral
representation in databases, software advances, and the
development of novel bioinformatic tools (Table 3), is essential
for continuing to improve the proportion of true phageomes
captured by viromic analysis and understanding their functions.
Another limitation associated with assembled viral genomes
is the lack of information on viral activity (Stern et al., 2012).
Sequenced phages may be quiescent and thus less metabolically
important relative to the active phage community. Further, the
verification of host range, gene function, and replication strategy
characterisation requires the cultivation of phage isolates. The
activity of phages can, however, be resolved through a
combination of ‘omic strategies. In a similar approach to
sequencing the DNA metagenome, other meta-’omic strategies
have been adopted to study the gut phageome at the RNA,
protein and metabolite-levels.
Other ‘Omics
In metatranscriptomics, the sequencing and de-novo assembly of
RNA contigs is carried out in a similar way to metagenomics,
reviewed for environmental samples in (Lim et al., 2013).
Notably, for recovering RNA phages from the gut, there are
inherent difficulties facing the collection, storage and assembly ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7RNA libraries from human samples, which have been reviewed
by Bikel et al. (2015). This could be why metatranscriptomics has
had limited usage in the study of the gut phageome. In addition,
tools developed for the prediction of DNA phage contigs from
metagenomes are not optimised for the prediction of RNA
phages, due to the scarcity of known RNA phages and the vast
diversity in their genomes (Duffy et al., 2008). Subsequently,
RNA phages have rarely been identified in the gut; the RNA
viruses that have been identified were derived from plants
consumed in the diet (Zhang et al., 2005; Lim et al., 2015). A
novel alternative approach to recovering RNA phages, based on
homology to known core single-stranded RNA (ssRNA) phage
genes, has been implemented on metatranscriptomes generated
from activated sludge and aquatic environments (Callanan et al.,
2020). Future studies should aim to use this method to recover
RNA phages from the gut, given recent findings of their
abundance and activity in other ecosystems (Callanan et al.,
2018; Starr et al., 2019).
A second use of metatranscriptomics comes with its
combined implementation alongside metagenomics. By
mapping metatranscriptome reads to assembled phage
genomes, gene transcription can be estimated as a proxy for
phage activity to discern active from dormant prophages.
Further, the most actively transcribed genes can be determined
for the functional analysis of the phageome. When this combined
approach is applied to samples over a time-course, the dynamics
and persistence of phage infection can be determined, as shown
for marine ecosystems (Sieradzki et al., 2019). To the best
of our knowledge, metatranscriptomics has had limited
implementation on the gut phageome, but future efforts should
enable the investigation of active functional genes, including
auxiliary metabolic genes, and discern the proportion of the
phageome that is active within the gut microbiome in diseased
and healthy states. This could uncover further evidence for
implicating the phageome in disease.
Metaproteomics captures the protein complement of
microbial communities and is a direct study of the end
product of gene expression, used to evaluate the functional
state of a community. Downstream analytical techniques such
as mass spectrometry and nuclear magnetic resonance can be
implemented to characterize isolated proteins. Modern advances
in these techniques have improved the throughput and accuracy
of this approach for its application on the gut microbiome
(Arnold et al., 2016). Metaproteomics has been used to provide
further support for the dominance of temperate phages in the
gut, from an abundance of virally-encoded proteins associated
with lysogenic replication strategies (Ogilvie et al., 2013).
Additionally, metaproteomics has revealed phage proteins that
were not identified through genome-based alignment
approaches, indicating the advantage of a complementary
multi-’omic strategy (Ogilvie et al., 2013). Other applications
of proteomics on the gut phageome are very rare in the literature,
but have been proposed to uncover the functional potential of
phages (Shkoporov et al., 2019). Like metatranscriptomics, future
metaproteomic analysis should enable inferences on the relative
functional state of the phageome in the gut through comparative
and longitudinal studies.June 2021 | Volume 11 | Article 643214
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within cells, thus including those involved in lysogenic
conversion. In gut microbiome research, metabolomics has
been used to evaluate the metabolic state of the gut
microbiome as a result of phage predation (Hsu et al., 2019).
This approach facilitates the direct monitoring of phage function
in the gut, moving beyond the correlation of phage populations
with those of their host. Future use of metabolomics could be
applied to explore the role phages play in microbial community
function, interactions with the human host and differences in
phage-mediated community function between healthy and
diseased states (see section Role of Bacteriophages in
Human Disease).
The methods used to identify and characterize phages have
come a long way since phages were first visualised in 1940
(Figure 1). Early culture-dependent methods isolated intestinal
phages from faeces for the first time, microscopy enabled the
morphotypes and abundances of gut phages to be realised, and
recent ‘omic advances have facilitated the study of phageome
diversity and function.
There are undoubtedly numerous additional challenges that
face the study of the phageome, as compared to the bacterial
microbiome. While we have provided many limitations of the
existing methods, we have underlined the potential for their
future development and implementation in studying the gut
phageome. Namely, the greatest challenge involves expanding
the proportion of the phageome captured by ‘omic analyses. This
means recovering increasingly low abundant phage populations
and describing their functional potential and reality. To this aim,
future advances in both culture-dependent and sequencing
methods, in addition to the combination of these approaches,Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8can be achieved in a number of ways. This begins with amending
sampling biases through the direct study of gut samples, and the
greater representation of sampled individuals outside of Europe
and North America. Increasing sequencing depth, augmenting
bioinformatic tools for recovering and annotating phage contigs,
and combining ‘omic techniques will maximize our ability
to characterize sampled phageomes. The simultaneous
implementation of culture-dependent methods with sequencing
approaches can validate in silico hypotheses of phage-host
interactions for implicating phage populations in the overall
functioning of the gut.COMPOSITION OF THE GUT
PHAGEOME
Development of the Phageome
The human gut is host to a complex community of
microorganisms that contribute greatly to gut function,
immune responses and disease pathogenesis. The human
microbiome develops from birth, is predominantly of maternal
origin, and expands rapidly in response to many environmental
factors (Yassour et al., 2016). The phageome follows a similar
pattern to the bacterial populations, with changes in diversity
occurring within the first 2 weeks of life (Figure 3) (Breitbart
et al., 2008). Initially the phageome is of low diversity, with the
sources of inoculation being unclear (Mills et al., 2013).
Suggestions of the origin of this initial phageome include
dietary, environmental and maternal sources (Breitbart et al.,
2008), and induction of prophages from the newly colonisedFIGURE 3 | Changes in the gut phageome over the human lifetime. Pie charts represent the observed ratios of different phage groups at discrete sampling times,
from birth where no endemic phages were observed to adults, while the humped line describes changes in phage diversity and abundance over time, which both
peak in the weeks after birth (Breitbart et al., 2008; Reyes et al., 2010; Kim et al., 2011; Lim et al., 2015; McCann et al., 2018).June 2021 | Volume 11 | Article 643214
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are also derived from the maternal source, these should not be
considered distinct sources but rather a multifaceted acquisition.
It has been reported that vaginal delivery or caesarean section
can produce distinctly different viral communities within the
infant gut phageome (McCann et al., 2018). Bifidobacterium and
their phages can be vertically inherited from the mother via
breastmilk (Duranti et al., 2017), including prophage induced
from colonizing bacteria (Liang et al., 2020) and phage that infect
probiotic lactic acid bacteria abundant in breastmilk (Martin
et al., 2003; Pannaraj et al., 2018). Sharon et al. (2013) found that
a group of closely related Caudovirales bloomed, then persisted
in the infant gut along with their host strains, between weeks
15-24 after birth. These Caudovirales initially dominate the gut
phageome, then a shift to a Microviridae-dominated population
occurs at around two and a half years old (Figure 3) (Lim et al.,
2015). It has been postulated that the Caudovirales populations
cannot be supported by the minimal bacterial community,
leading to a phage population crash. This, in turn, allows
bacterial populations to thrive without predation, shifting the
microbiome towards a mature state with an increased diversity
of bacteria.
In adulthood, the gut phageome has been proposed to be
dominated by phages exhibiting a temperate lifestyle (Silveira
and Rohwer, 2016). While this may be true, measures of the
phageome are not absolute and the diversity of temperate phages
may be masked by a few highly abundant lytic phages, meaning
that the intricacies of the phageome have yet to be fully resolved
(Sutton and Hill, 2019). The adult gut phageome shows a return
to a Caudovirales-dominant population with a subpopulation of
Microviridae (Figure 3) (Kim et al., 2011; Manrique et al., 2016),
although there is a large degree of inter-individual variation
(Reyes et al., 2010). Communities dominated by Microviridae or
CrAssphage have also been described in some individuals
(Shkoporov et al., 2019). This inter-individual diversity appears
to be driven by environmental factors (Reyes et al., 2010), and is
significant even between identical twin infants and families (Lim
et al., 2015; Reyes et al., 2015). Some RNA phages have also been
detected in the gut phageome, but in significantly lower
abundance in comparison to DNA phages (Breitbart et al.,
2003; Zhang et al., 2005). However, it is difficult to distinguish
if this is due to a genuine reduced presence or lack of effective
techniques to detect RNA phages, as discussed in section Other
‘Omics. Later in life, the gut microbiome decreases in diversity
and shifts from a Firmicutes- and Bacteroidetes-dominated
community to one dominated by obligate and facultative
anaerobes (Nagpal et al., 2018). While it has yet to be
investigated, the functional capacity of the phageome may also
be influenced by this change in composition. Though the gut
phageome seems to be highly specific from person-to-person,
there has been indication of stability over time (Shkoporov et al.,
2019), with sequences of the same phages detected more than 2
years apart (Minot et al., 2011; Minot et al., 2013). There is
emerging evidence for a core gut phageome, Manrique et al.
(2016) identified a set of 23 phages that were present in over 50%
of healthy gut samples analysed, with an additional 44 phageFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9groups present in 20-50% of individuals, suggesting a secondary
set of shared phages. A recent study found that both CrAssphage
and Microviridae were the two most stable members of the gut
viral community, suggesting a potential role as part of a core
phageome (Shkoporov et al., 2019). However, any core
communities only represent a fraction of the overall
population, it is almost impossible to simplify the complexity
and individuality of the phageome.
Identification of Novel Human Phages
CrAssphage were discovered in 2014 via the cross-assembly
(crAss) method, providing the name CrAssphage. Previously
undetected, they are the most abundant gut phage currently
known (Dutilh et al., 2014). Through both metagenomic
and culture-based studies, their host has been predicted to be
Bacteroides, with a podoviridae-like morphology (Shkoporov
et al., 2018a; Yutin et al., 2018). Interestingly, no known
lysogeny genes were found in the genome of the original
CrAssphage isolate (crAss001), yet the phage could maintain its
population in culture with Bacteroides intestinalis, in part due to
the long latent phase and very small burst size of 2.5 plaque
forming units per cell. However, the true mechanism was
not elucidated.
There is evidence to suggest that CrAssphage has long been a
member of human gut phage communities, having also been
found in the gut of non-human primates, such as baboons and
gorillas (Edwards et al., 2019). This presents the idea that
CrAssphage have evolved with humans and maintained their
presence in the gut phageome. Furthermore, CrAssphage
sequences have been found to persist universally across the
globe. The majority of strains identified were only present in
individual samples, however one strain was identified in 104
independent samples spread across multiple continents
(Edwards et al., 2019). In addition, CrAssphage was more
abundant in the gut of industrialised populations in
comparison to traditional hunter-gatherer populations (Honap
et al., 2020). These findings, taken together, suggest a recent
human expansion event, associated with industrialisation, led to
the expansion of CrAssphage within the human population.
The presence of CrAssphage in the gut appears to begin in
infancy (McCann et al., 2018; Edwards et al., 2019; Shkoporov
et al., 2019). It appears to be transmitted vertically, with
homology found between isolates from mother and child
(Siranosian et al., 2020), which also corresponds with the
presence of its Bacteroides host (Tanaka and Nakayama, 2017).
However, there is again a large degree of inter-individual
variation in the presence and abundance of CrAssphage.
A group of megaphages (with genomes > 500 kb in length)
have been identified from human faecal samples and have been
tentatively predicted to infect Prevotella (Devoto et al., 2019).
These “Lak phages’’ were detected in a wide range of samples and
are exceptional, not only for the size of their genomes but also,
for their use of a genetic code with an alternative stop codon,
setting them apart from other phage families (Devoto et al.,
2019). Lak phages are yet to be isolated, but the size of their
genomes again raises the question of how many large (> 200 nm)June 2021 | Volume 11 | Article 643214
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Dependent Methods).
Unusual, composite phages have also been identified to play a
role within the gut. Bacterial strain Enterococcus faecalis V583
contains multiple prophage elements, two of which combine to
form a lytic phage particle (Duerkop et al., 2012). One of these
distinct prophages encodes the structural proteins, while the
other contains necessary infection elements, and both are
essential for lytic infection. The resultant phage appears to give
E. faecalis V583 a competitive advantage over related strains
when colonizing the gut (Duerkop et al., 2012) (see discussion in
section Phage-Host Population Dynamics). While being of
interest as a stand-alone case, this also has implications for
future metagenomic studies when partial prophage-like
sequences are found.
Longitudinal Distribution of Phages in the
Gastrointestinal Tract
The location within the gut also influences the phageome (Figure
2). Following the stomach, the proximal gut provides the most
hostile environment for bacteria, a microaerophilic environment
with a low pH and antimicrobial peptides which enriches
bacteria such as Lactobacillaceae and Enterobacteriaceae. The
distal gut is the opposite, an anaerobic environment, with a
higher pH and reduced concentration of antimicrobial peptides,
allowing bacteria such as Bacteroidaceae, Prevotellaceae and
Ruminococcaceae to thrive (Donaldson et al., 2016). This
longitudinal gradient causes a steady increase in bacterial load
and diversity from the proximal to the distal gut, and it may be
expected that the phage distribution would also follow this
longitudinal axis. In primate models, it has been shown that
both the relative abundance of phages and the composition of the
phageome varies depending on site within the gastrointestinal
tract (Zoetendal et al., 2012; Zhao et al., 2019). Furthermore, a
study in pigs found a higher abundance of phages in the ileum,
and hypothesised that the nutrient-limited environment may
prevent bacterial phage resistance and promote pseudolysogeny,
allowing phage proliferation (Looft et al., 2014). The density of
phage populations also varies cross-sectionally through the
mucus layers of the gut (Barr et al., 2013a), the implications of
this are discussed further in section Interactions With the
Immune System. These differences in phage communities hint
at the different roles and functions of phages throughout the
gastrointestinal tract, that require greater understanding to use
phages in the future as markers of gut health or as treatments to
improve gut function. In Figure 2 we have displayed the varying
composition of the phageome throughout the digestive tract,
where the majority of the knowledge arises from faecal samples.
Impact of Diet on the Phageome
A well-characterised influence on the gut microbiome is diet,
therefore it can be assumed that diet will impact the phageome
too (Singh et al., 2017). This has been observed in studies of high
fat diet (HFD) in mouse models, wherein both the microbial and
viral gut communities were affected (Howe et al., 2016; Schulfer
et al., 2020). These changes to the phageome during a long-termFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10HFD included an increased abundance of Microviridae, while
Siphoviridae abundance decreased (Schulfer et al., 2020). As
breast milk is high in fat, this may provide some insight into
why previous studies have found that infant gut phageomes
move towardsMicroviridae-dominated communities (see section
Development of the Phageome) (Figure 3). The change of diet in
infancy, to weaning and solid foods was shown to alter gut phage
composition and diversity in pandas (Guo et al., 2020),
suggesting the change from infant to adult phageome is in part
influenced by dietary factors. Malnutrition in infancy was also
found to affect the gut phageome (Reyes et al., 2015). The
microbiome and phageome developed sequentially, but the
phageome was disrupted in malnourished infants (Reyes et al.,
2015). Phage populations could not be recovered, despite the use
of dietary supplements, suggesting that infancy is a key time in
the development of the gut phageome (Reyes et al., 2015).
Further studies have identified that the phageome is not only
distinct in malnourished children, but in fact these phages may
play a pathophysiological role (Mirzaei et al., 2020). In vitro
experiments indicated phages from a stunted child caused
microbiota shifts to a disease associated state in an age-related
manner (Mirzaei et al., 2020). The study suggested there is a time
window where the phageome and microbiome of children less
than 23 months is amenable, before the malnutrition-associated
community becomes fixed. As malnutrition and stunting of
growth is a major cause of mortality in infants, this finding is
of great importance.
Once the phageome is established it is less influenced by diet,
but increasing fat does seem to have an impact. Increased fat
leads similar shifts in the gut phageome, however there was still
great inter-individual variation (Minot et al., 2011). This suggests
that the phageome is not acquired through diet, but that the diet
shapes existing communities (Minot et al., 2011). In addition,
consumption of various foods can influence prophage induction
in the resident gut microbiota (Kennedy et al., 1984; Jofre et al.,
1995; Méndez et al., 2004).
Numerous studies have identified food products that are a
rich source of bacteriophages, yet there is little evidence if or how
they influence the phageome. Coliphage can be found in a variety
of food sources, and are used as an indicator of faecal
contamination (Kennedy et al., 1984; Kennedy et al., 1986;
Jofre et al., 1995; Méndez et al., 2004). Gut viruses include
eukaryotic and plant viruses that arrive in the gut via the oral
route (Liu et al., 2013), which have been demonstrated to make
up a high proportion of RNA viruses detected in the gut (Zhang
et al., 2005). There is also evidence of bacteriophages surviving
food decontamination processes, such as fermented foods;
including soy beans (Chukeatirote et al., 2018), sauerkraut
(Yoon et al., 2002; Lu et al., 2003), cheese (McIntyre et al.,
1991; Quiberoni et al., 2006), yoghurt (Ma et al., 2014; Ma et al.,
2015), fermented vegetables (Lu et al., 2003; Kleppen et al., 2012),
fermented meats (Trevors et al., 1984), drinking water (Armon et
al., 1997) and heat-stable phages surviving dairy product
pasteurisation (Suarez et al., 2002; Murphy et al., 2014).
Furthermore, in recent years, there has been a rise in the
consumption of unpasteurised milk, unfortunately linked to aJune 2021 | Volume 11 | Article 643214
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has been demonstrated to be an abundant source of new
bacteriophages, containing up to 104 bacteriophages per mL of
product (Marco et al., 2012). To date, no studies have examined
the effect of dietary phage intake to understand the impact of
normal dietary intake on the phageome and wider microbiome.
Bacteriophages are currently being used to make food safer
and have been used as indicators for the virological safety of food
(Allwood et al., 2004), as alternatives to antibiotics in animal
husbandry (Cheng et al., 2014; Gigante and Atterbury, 2019), in
food decontamination (Moye et al., 2018), to increase yield or
quality (Zhao et al., 2012), and to prevent spoiling (Sillankorva
et al., 2012). Table 4 displays a list of bacteriophage products
approved for use in food manufacturing. As the use of these
phage products become increasingly more common, their
abundance in the human diet is likely to increase; the impact
on the human gut microbiome is currently unknown. Drinking
water is another potential source of phages, regardless of high
quality water treatment systems and microbiologically safe
drinking water, viruses survive the process (Armon et al.,
1997). While large scale changes due to dietary consumption
of phages appear transient, there is the potential for a variety of
viruses to enter the digestive system and influence the
human host.
The human gut is an abundant source of potential host
bacteria, which should allow many dietary phages to thrive.
Equally there are a number of factors that may prevent
colonisation by dietary phages, including phage-specific
antibodies (Mirzaei and Maurice, 2017), eluded to by a higher
abundance and diversity within the phageome of patients with
immune disorders (Norman et al., 2015; Perez-Brocal et al.,
2015). Phage colonisation may be further hampered by various
exclusion strategies by host strains (Rossmann et al., 2015) and
phage competition (Reyes et al., 2013). It has been shown that
orally delivered phages can survive the stomach to be detected in
the faeces, while some phage treatments reduce target bacteria
(Mai et al., 2015), not all phage-host systems are equal and someFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 11phages fail to proliferate (Sarker et al., 2016). With GI tract
phageome studies limited in scope and number, the lack of direct
supporting evidence for dietary phages to shape the phageome
and microbiome does not mean that they play no role. Instead, it
is another overlooked aspect of the human gut microbiome,
particularly in the first two formative years.
Impact of Medical Interventions on the
Phageome
Medical procedures and treatments can have an effect on the gut
phageome, including the well-documented impact of antibiotics.
The effect of broad spectrum antibiotics on the gut bacterial
community is non-targeted killing, leading to a dysbiotic state
(Jernberg et al., 2010), which may in turn affect the phageome. In
rhesus monkeys there has been an observed decrease in viral
abundance and diversity following antibiotic treatment (Li et al.,
2019), but no detectable change in the gut phageome was found
in human studies of long-term antibiotic use (Abeles et al., 2015).
It may be that disturbances in the gut viral community caused by
antibiotics are rapid, and during long-term exposure the
community re-adjusts and stabilises. In the short-term,
prophage induction has frequently been demonstrated upon
antibiotic exposure due to host DNA damage and initiation of
the bacterial SOS response, in turn activating prophages and
potentially increasing the likelihood of horizontal gene transfer
(Maiques et al., 2006; Allen et al., 2011; Lin and Lin, 2019),
further discussed in section Virus-Mediated Genetic Exchange.
This has consequences for subsequent antibiotic usage, if a
reservoir of phage-encoded antibiotic resistance genes is
established in the gut (Modi et al., 2013; Abeles et al., 2015).
Faecal microbiota transplant (FMT) is the transfer of faecal
material from a healthy donor to an individual with
gastrointestinal disease with the intention to restore a healthy
gut microbiome. It has been shown that the phage component is
of high importance in FMT, able to improve efficacy (Bojanova
and Bordenstein, 2016; Zuo et al., 2018) and remains effective
without the bacterial fraction of FMT (Ott et al., 2017).TABLE 4 | Phage products approved for use in food manufacturing. These phage products have the opportunity to enter the GI tract and impact the gut phageome.
Manufacturer Product Applications
Intralyx Inc. (MD, USA) ListShield™ Targets Listeria monocytogenes contamination in foods and food processing facilities.
EcoShield™ Targets Escherichia coli, and Shiga toxin producing E. coli in particular, including O157:H7 STEC.
SalmoFresh PX™ Targets contamination with selected, highly pathogenic Salmonella-serotypes in foods and food processing
facilities.
ShigaShield™ Targets contamination with Shigella spp. in foods and food processing facilities.
APS Biocontrol (Dundee, UK) Biolyse®-PB Targets bacteria that cause soft rot on potatoes mainly, Erwinia spp., Pectobacterium spp., and Pseudomonas
spp.
Proteon Pharmaceitocals BAFASAL® Targets human-pathogenic Salmonella spp. in poultry farming.
BAFADOR® Targets Pseudomonas spp. and Aeromonas spp. in commercial aquaculture
Elanco (IN, USA) Finalyse™ Pre-slaughter hide wash applied to live cattle, targeting E. coli O157:H7




Surface treatment targeting Listeria monocytogenes on a number of food products such as, meat, fish, cheese
and frozen vegetables.
PhageGuard S™ Targets Salmonella spp. on fresh poultry.
PhageGuard E™ Targets E. coli O157 on beef carcuses.
OmniLytics (UT, USA) Agriphage™ Targets Xanthomonas campestris. Xanthomonas vesicatoria and Pseudomonas syringae to prevent bacterial spots
tomatoes and peppers.June 2021 | Volume 11 | Article 643214
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be due to an alteration of the patient’s own phageome or the
predatory action of the donated phages. A number of studies
have looked at the potential of faecal virome transplants (FVT)
from one individual to another, which could assist recovery after
antibiotic-induced dysbiosis (Draper et al., 2019).
In contrast with the microbiome, there has been limited
success in defining a core phageome. The phageome is highly
specific to an individual and its resilience to change over time
raises interesting questions. The phageome appears to remain
relatively constant, while we know the microbiome fluctuates
over time and with environmental factors. But are there as yet
undetected effects on the phageome? Do phage populations
remain dormant for a long time, persisting in host populations,
or is their host range wide enough that they continue to
encounter hosts regardless of fluctuations in bacterial
populations? We know that phages are consumed in the diet,
and it is assumed with the survival of other viruses, phages also
survive the human gastrointestinal tract. If this is the case, are
phages able to colonize the gut once they reach it? As seen with
FMT, this appears to be possible as phages seem to be the key to
success of this treatment. However, the stability of the phageome
within an individual suggests that no such invasion and
colonisation occurs. Answering this myriad of questions is
hampered by the sampling method used to study the
phageome: metagenome sequencing of faeces (see section
Metagenomics). Measuring phage activity throughout the GI
tract over a time course would help to elucidate fluctuations in
the phageome at sites where it could impact human health and
gut function. As this is still an emerging field, we hope with
greater investigation the phageome will reach a level of
understanding we see for the microbiome.PHAGEOME, GUT BACTERIA, AND
HUMAN HOST INTERACTIONS
Given that most phages infect and eventually lyse specific
bacterial hosts, the gut bacterial community shapes the phage
community, as much as it is shaped by phages. Phage-host
interactions occur in a number of context-dependent dynamics
throughout the gastrointestinal tract, playing roles in the cycling
of nutrients, community function and transfer of genetic
material. The role of the phageome is seen primarily through
its influence on the function of the bacterial community,
however there are further consequences of their presence in
the gut, including on human immune responses, impacts on
human health and gut-associated bacterial biofilms.
Phage-Host Population Dynamics
In the human gut, the phageome is thought to affect succession
and colonisation events (Lozupone et al., 2012; De Sordi et al.,
2019; Shkoporov et al., 2019), it is well known that phage
contribute to feedback loops and predation which influence the
dominance and diversity within a microbial population. Broadly
speaking, there are three main dynamics under which the
phageome will be able to alter the gut microbiome: Red QueenFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12dynamics [continual evolution of defence and counter-defence
measures (Table 5)] (Van Valen, 1973), kill-the-winner (lysis of
common genotypes, preventing dominance) (Maslov and
Sneppen, 2017), and piggyback-the-winner (lysogeny allowing
phage and bacteria to stably co-exist) (Weitz and Dushoff, 2007).
On the mucosal surfaces of the gut, the bacterial population is
spatially structured through the surrounding mucus. The lifestyle
of phages is dependent on host availability: less available hosts,
lytic predation takes place, and otherwise, lysogeny is the key
mode of phage lifestyle (Figure 4). It is theorised this kill-the-
winner strategy promotes elimination of potential pathogens
deep in mucus layers, while a lysogenic piggyback-the-winner
strategy provides an advantage for bacterial commensals against
niche invasion (Silveira and Rohwer, 2016).
As a consequence of these changes and alterations in phage
dynamics and prevalence in the human gut, it is possible that no
specific genotypes maintain dominance, but are constantly
superseded by functionally equivalent strains, maintaining
stable metabolic potential and taxonomic diversity. This
functional redundancy is known to be favoured in the bacterial
microbiome (Ley et al., 2006), allowing more resilience and less
impact of dysbiotic perturbations (Vieira-Silva et al., 2016).
Virus-Mediated Genetic Exchange
Bacteriophages are able to influence evolution and diversification
of bacterial communities through horizontal gene transfer
(Wommack and Colwell, 2000; Koskella and Brockhurst,
2014). As previously discussed, lysogenic phage and prophage
dominate the human gut (Breitbart et al., 2003; Reyes et al., 2010;
Minot et al., 2011). Lysogenic conversion of bacterial phenotype
has been shown to contribute to 5% of the conserved
microbiome function in the human gut, indicating these
prophage exert a strong influence over the microbial function
in this environment (Qin et al., 2010). The effects of genetic
exchange are well-studied in pathogenic species, but have also
been demonstrated in human gut commensals such as
Lactobacillus gasseri (Baugher et al., 2014).
Further to the impact on the bacterial hosts, viral genetic
exchange from the gut microbiome has wider implications for
the mammalian host, with viral integrases being shown to
mediate chromosomal integration in human cells (Groth et al.,
2000). The larger impact of this has yet to be explored.
Due to the global threat of rising antimicrobial resistance, the
contribution of viral genetic exchange has been studied in depth
(Balcazar, 2014). It has been theorised that bacteriophage could
be the missing link, transferring antimicrobial resistance genes
(ARGs) from the environment into the human microbiome, as
well as between bacteria within the microbiome (Muniesa et al.,
2013; Quiros et al., 2014). Phages may contribute more to the
dissemination of these genes compared to plasmids and
chromosomal elements, both over time-scale and wider spaces
(Debroas and Siguret, 2019). This will be especially important in
the densely populated human gut, where numerous transduction
events potentially occur at any given moment. In a mouse study,
after exposure to antibiotics, there was an enrichment of phage-
encoded genes associated with antibiotic resistance and/or
antibiotic mitigation in faecal samples (Modi et al., 2013).June 2021 | Volume 11 | Article 643214
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classes. Critically, these phage-encoded genes were shown to be
functional through transfecting antibiotic naïve mice (Modi
et al., 2013). On a cautionary note, while these phages were
able to transfer antibiotic resistance between mice, the true rate
of antibiotic resistance encoded by phages is much lower than
predicted by bioinformatic methods (Enault et al., 2017). Despite
this, phages can facilitate the release and exchange of plasmid-
encoded ARGs when they lyse their hosts.
Cycling Key Nutrients
Nutrient cycling by phages is well-characterised in environmental
systems, such as marine and soil ecosystems. The “viral shunt”
explains how carbon and other intracellular nutrients are released
upon lysis of host cells into the extracellular milieu. (Wilhelm and
Suttle, 1999). The human gut has significantly more available
nutrients compared to marine and soil systems, leading to the
extremely high cell densities, resulting in more competition for
available nutrients. Examples of key nutrients which are limited
for the gut microbiota are iron and vitamin B12 (cobalamin)
(Deriu et al., 2013; Degnan et al., 2014). It has been proposed that
gut viruses play a role in alleviating this competition, limiting
growth, regulating community stability and nutrient cycling, as
observed in other systems (Lozupone et al., 2012). Due to the high
degree of interindividual gut community variation, it is difficult to
pinpoint how the phageome alters nutrients in the gut or is itself
altered by incoming nutrients from the human host diet (see
section Impact of Diet on the Phageome) (Minot et al., 2011; David
et al., 2014).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 13Interactions With the Immune System
While phage interactions with their bacterial hosts are of vital
importance, phage interactions with the human host are also
paramount. There is evidence that the phageome is able to
influence both the innate and adaptive system, playing a
defensive role at the gut mucosa (Barr et al., 2013b; Barr et al.,
2015). It has been shown that immune stimulation can be caused
by a number of phage proteins (Majewska et al., 2015;
Miernikiewicz et al., 2016), and possibly cause a low-grade
inflammation in the intestines, without any clinical symptoms
(Norman et al., 2014). However, the correlation of phage in FMT
with positive outcomes in inflammatory bowel disease
(Gogokhia et al., 2019) [see section Inflammatory Bowel
Disease (IBD)] suggests a more complex relationship between
the phageome and individual human health.
Phage proteins, not involved in the attachment to the
bacterial host, have the ability to instead attach to the gut
mucosa. These adhesins have been identified on the capsid,
collar whiskers and tail shaft of the phages, and possess
immunoglobulin-like (Ig-like) domains (Fraser et al., 2007;
Barr et al., 2013a). Along with these Ig-like domains, regions
of hypervariability in the virus tail fibres help to mask phages
from the immune system (Doulatov et al., 2004; Minot et al.,
2012). The Ig-like domains additionally function to bind the
phages to the mucus, allowing phages to form a defensive barrier
over mucosal membranes (Figure 4). This barrier is evidence of a
symbiotic coevolution between phages and the human host, by
enabling phages to come into contact with bacterial prey and
regulating the bacterial populations at this surface, benefitingTABLE 5 | Summary of bacteria-encoded phage defence mechanisms.
Mechanism Infection stage disrupted Example references




with protein Phage attachment and adsorption Staphylococcus aureus (Nordström and
Forsgren, 1974)
Escherichia coli, preventing superinfection
(Pedruzzi et al., 1998)
with
polysaccharides
Escherichia coli (Stummeyer et al., 2006)
Phase variation of phage receptors Phage attachment and adsorption Bordetella pertussis (Uhl and Miller, 1996)
Production of competitive inhibitors to
phage receptors
Phage attachment and adsorption Escherichia coli (Destoumieux-Garzón
et al., 2005)
Superinfection exclusion (Sie) systems,
often encoded for by prophage.
Block phage DNA entry into cell. Escherichia coli (Lu and Henning, 1994)
Salmonella sp. (Hofer et al., 1995)
Lactococcus lactis (Akçelik, 1998)
Streptococcus thermophilus (Sun et al., 2006)
Bacteriophage exclusion (BREX) Prevents phage DNA replication. Bacillus cereus (Goldfarb et al., 2015)
Restriction-modification systems Degrade phage DNA. Staphylococcus aureus (Sjöström et al., 1978)
Salmonella (Bullas et al., 1976)
Defence island system associated with
restriction–modification (DISARM)
Degrade phage DNA. Type of R-M system. Bacillus paralicheniformis (Ofir et al., 2018)
CRISPR/Cas elements Result in degradation of phage nucleic acids. Streptococcus thermophilus (Deveau
et al., 2008)
Abortive infection (Abi) Prevent phage multiplication (replication, transcription, or translation).
Result in death of infected host cell.
Lactococcus lactis (Chopin et al., 2005)
Escherichia coli (Molineux, 1991)
Toxin-antitoxin Leads to abortive infection. Pectobacterium atrosepticum (Fineran
et al., 2009)
Escherichia coli (Pecota and Wood, 1996)June 2021 | Volume 11 | Article 643214
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shown to be actively transported across the gut epithelium, by
transcytosis to variable degrees (Bruttin and Brussow, 2005;
Gorski et al., 2006; Nguyen et al., 2017) (Figure 4), meaning
there is more opportunity for interaction with immune cells
outside of the gut.
It is clear from the summative research conducted that
phages, in addition to affecting their bacterial hosts, impact the
health of the human or mammalian hosts in which they reside.
This could have an important impact for numerous diseases, as
discussed later in section, Role of Bacteriophages in
Human Disease.
Phage Behaviour Within a Biofilm
Environment
There is evidence to suggest that the majority of microbial life
within the gastrointestinal tract exists as a biofilm, a distinct
lifestyle to planktonic bacteria (Costerton et al., 1987; Macfarlane
and Dillon, 2007; Hussain et al., 2020). As the bacterial host
behaves significantly differently within a biofilm-dominated
environment, it is important to consider how this will impact
phage behaviour which is predominantly investigated in
planktonic in vitro settings.
The biofilm within the gut lumen performs multiple
functions, but one of the most important is acting as a physical
barrier to the mucosa. Commensal bacteria are able to form a
protective coating over the mucosa which will preventFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 14pathogenic bacteria penetrating to the epithelial cell layer
(Iacob et al., 2019). However, pathogenic bacteria may invade
the biofilm, lay dormant and benefit from the surrounding cells
by acquiring ARGs and evading host defences. This may then
lead to a disease state when the cells exit dormancy (Tytgat
et al., 2019).
The self-produced extracellular matrix (ECM) of a biofilm is
recognised as a protective coating of cells, preventing diffusion of
small molecules through the bacterial population (Flemming and
Wingender, 2010). Numerous phages have been shown to
encode depolymerases which are able to degrade ECM,
allowing them to make contact with host cell receptors
(Hughes et al., 1998). As these are widespread, it appears to
indicate that the ECM is a major barrier to phage infection (Pires
et al., 2016).
However, phages are also able to promote the formation of a
thicker biofilm, which as previously stated can be associated with
disease. Quorum sensing, a communication system within
biofilms, is able to induce temperate phages. These phages are
then able to contribute to HGT within the biofilm, as well as
bacterial host evolution and adaptation through insertional
activation of genes (Rossmann et al., 2015; Davies et al., 2016).
Phages can also provide physical additions to the ECM, through
both the presence of phage particles, and released cellular
contents after lysis, particularly eDNA (Rice et al., 2009;
Schuch and Fischetti, 2009; Carrolo et al., 2010; Wang et al.,
2010; Shen et al., 2018).FIGURE 4 | Diagram of the gut and bacterial and phage concentrations in the lumen, mucosa and epithelial cells. In the human gut, multiple different host-prey
dynamics are theorised to occur dependent on the proximity to the gut mucosa. At the top of the mucosa, viruses take a lysogenic strategy or “piggyback-the-
winner” as hosts are abundant here. Deeper within the mucosa, the viruses switch to a lytic or “kill-the-winner” strategy as at this point the bacteria are less
abundant (Silveira and Rohwer, 2016). (Right) Some phages encode Ig-like domains that allow them to bind to the mucosa and evade the immune system,
(Left) Phages can undergo transcytosis and be engulfed and transported through epithelial cells.June 2021 | Volume 11 | Article 643214
Townsend et al. Gut Phageome: Origins and RolesThe presence of biofilm in the gut lumen is a double-edged
sword; it protects the human host but has the potential to harbour
pathogens and enhance disease, as seen in inflammatory bowel
disease (Swidsinski et al., 2005). Equally, phages can both
promote or disrupt this biofilm state. Therefore it is difficult to
say what the wider impact of phage populations are in this case.
These interactions should be considered before the application of
phage therapy, where there may be unintended consequences of
disrupting “healthy” biofilms or enhancing “diseased” biofilms.
Understanding how a single phage interacts with its infection
host is quite different to how a population of phage interacts with
not only bacteria but human cells, fungi and archaea which may
dwell in the gut. It has been shown in vitro that a bacteriophage
can seemingly impact on Candida albicans, a dimorphic fungus
that can be found in the gut (Nazik et al., 2017). In this section, we
explained how phages may prime the immune system, but to our
knowledge there is no investigation into interactions with other
non-bacterial cells. As gut communities become more widely
studied, this may soon be elucidated. Having a controlled system
is beneficial as it allows determination of these minute
interactions, but it is no use if it does not reflect the in vivo
situation. One in vitro system which could be utilised complex
interaction studies, is a gut fermentation model seeded with faecal
samples, currently used in the study of phage therapy for
C. difficile (Nale et al., 2018). By expanding to a more “wide-
angle lens” of phage interactions, would open the possibility to
discover important off-target effects in microbial and human cells.ROLE OF BACTERIOPHAGES IN HUMAN
DISEASE
In recent years, our understanding of the intestinal microbiome
has increased to encompass the ways in which it impacts on
human health and disease. The majority of this research has
focussed on the bacterial populations, yet the phageome is also
expected to have a distinct role in shaping the gut environment
(Table 6). Even plant viruses which enter through the diet
(section Impact on Diet on the Phageome), such as Pepper mild
mottle virus, elicit an immune response in humans. This suggestsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 15that viruses’ effects are not limited to infective host range (Colson
et al., 2010).
Phages can have both direct and indirect impacts upon the
gut environment, leading to systemic consequences for human
health. Phage predation of gut bacteria, particularly those that
have protective roles in human health, can lead to dysbiosis
and disease.
For example, the diseased gut environment can be
inflammatory, leading to prophage induction in Salmonella,
causing bacterial lysis and initiating gut dysbiosis (Diard et al.,
2017). As previously discussed in section Interactions With the
Immune System, phages can also control populations of invasive
bacteria in the gut and have a role maintaining the intestinal
barrier function (Barr et al., 2013a). Conversely, gut phages can
also directly increase intestinal permeability, leading to
translocation of bacteria and bacterial products from the gut
into the bloodstream, which contributes to a chronic
inflammatory response (Tetz et al., 2017).
Inflammatory Bowel Disease (IBD)
Crohn’s disease (CD) and ulcerative colitis (UC) are the two
major types of IBD. CD is characterised by chronic inflammation
throughout the gastrointestinal tract, most commonly impacting
the ileum and colon, whereas UC involves inflammation and
ulceration limited specifically to the colon and rectum. CD can
affect the entirety of the intestinal wall, leading to the
development of complications such as abscesses, fistulas and
strictures, whereas UC affects the inner intestinal lining to cause
crypt abscesses and cryptitis (Khor et al., 2011). Understanding
of IBD pathology has shown that genetic predisposition interacts
with the gut microbiota and environmental cues, leading to the
development of disease. On the surface IBD shows no obvious
direct links to the gut phageome, however we are only beginning
to understand how phages are an intrinsic part of the gut
community and how they are linked to IBD.
Individuals with CD may show an altered phageome
compared to healthy control subjects. Epifluorescent
microscopy of biopsies from both ulcerated and non-ulcerated
tissues, from CD and control patients, showed over 10-fold
higher VLPs in individuals with CD, than in the controlTABLE 6 | Summary of changes to the gut phageome in different disease states.
Disease Bacteriophage Richness Bacteriophage Diversity Reference
Crohn’s disease + + (Lepage et al., 2008)
+ + (Perez-Brocal et al., 2015)
+ (Norman et al., 2015)
– (Fernandes et al., 2019)
+ (Wagner et al., 2013)
Ulcerative colitis + (Lepage et al., 2008)
+ – (Zuo et al., 2019)
+ (Gogokhia et al., 2019)
Type 1 diabetes – (Zhao et al., 2017)
+ (Tetz et al., 2019)
Type 2 diabetes + (Ma et al., 2018)
Human Immuno Virus + (Li et al., 2012)
Cardiovascular disease +/- (Jie et al., 2017)
+ (Han et al., 2018)June 2021 | Volume 11 | Article 643214
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Siphoviridae, Myoviridae and Podoviridae morphotypes, and
were detected more frequently in non-ulcerated mucosa, when
compared to ulcerated tissues from the same individual (Lepage
et al., 2008). The diversity of the gut phageome is higher in CD
patients compared to healthy controls, and again higher in new-
onset compared to active CD patients (Norman et al., 2015;
Perez-Brocal et al., 2015). In contrast to these studies, (Clooney
et al. (2019) found little change in diversity of phage populations.
However, they did observe a reduction in health-associated
virulent phages, with an increase in unique temperate phage
populations which became predominantly lytic rather than
lysogenic (Clooney et al., 2019). Within UC patients, there
were subtle changes in the phageome during a disease flare up
or remission state. The authors highlighted again that it is
difficult to elucidate if these changes are initiated by the
bacterial or phage populations. Regardless, these viral markers
may be involved in mediating an inflammatory response, be
induced in response to the CD patients intestinal inflammation,
or potentially both.
In addition to a general increase in the abundance of phages
seen in patients with CD, the emergence of dominant phage
families has been studied in the gut viral community.
Caudovirales are the most dominant phage family present in
CD patient samples (Wagner et al., 2013; Norman et al., 2015;
Fernandes et al., 2019). An inverse correlation was observed
between Caudovirales richness and diversity compared to
bacterial richness and diversity, indicating that the increase in
Caudovirales is not linked to host numbers in CD (Norman et al.,
2015), but rather that phage may be the driving force behind
fluctuations in disease. A decreased abundance of Microviridae
has also been reported in CD patient samples (Fernandes
et al., 2019).
Bacteroides is commonly identified as the host of these phages,
with the two most prominent phages identified infecting
Bacteroides fragilis, a bacterium associated with healthy gut
function (Kang et al., 2010; Wagner et al., 2013). As Bacteroides
is the dominant bacterial population in CD, the role of these
phages may warrant further investigation (Murphy et al., 2008;
Andoh et al., 2011). As the levels of both phage and host increase,
this could indicate a lysogenic relationship or blooming of the
host in CD. Faecalibacterium prausnitzii also plays a key role
in CD and mediates anti-inflammatory effects; a reduction
in F. prausnitzii has been associated with the onset of CD
(Martinez-Medina et al., 2006). Metagenomic analysis shows
patients with IBD have increased numbers of F. prausnitzii
phages (Cornuault et al., 2018), suggestive of a predatory
phage function. Experimental administration of a phage
cocktail against pathogenic Enterobacteriaceae, Streptococcaceae
and Staphylococcaeceae, led to an off-target decrease
in gut Faecalibacterium abundance, considered indicative of
inflammation and a change in gut permeability (Tetz et al.,
2017). Potentially, these off-target phage effects evidence that
our knowledge of phage-host ranges may not be as narrow as we
expect, and could have a downstream impact on symbiotic gut
bacteria association with healthy gut function (Tetz et al., 2017).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 16It is often assumed that phage therapy minimally disrupts a
patient’s microbiome, however it may lead to unforeseen
downstream effects in the gut.
In parallel to CD, the gut mucosa of individuals with UC
contains an increased abundance of Caudovirales compared to
healthy subjects, though unlike in CD, a lower phage diversity is
seen (Zuo et al., 2019). Mouse studies associated this with
intestinal inflammation and a more severe disease presentation
(Gogokhia et al., 2019). A specific increase in Escherichia,
Streptococcus and Enterobacteria phages is seen in UC patients
(Zuo et al., 2019). Previous research has found the abundance of
these bacteria to be lower in those with UC when compared to
healthy controls, suggesting predatory phage or prophage
induction, rather than the phageome mirroring host bacteria
abundance (Michail et al., 2012). Furthermore, phage functions
associated with host bacterial fitness and pathogenicity were
higher in the UC gut mucosa (Zuo et al., 2019). In mouse studies,
those with colitis have more phages which are not associated
with their bacterial hosts, suggesting a state of intestinal dysbiosis
(Duerkop et al., 2018). In a number of studies with UC patients,
inflammation of gut mucosa translated to an increase in viruses,
particularly Caudovirales phages, when compared with the non-
inflamed mucosa, indicating that Caudovirales could play a
direct role in inducing inflammation in the gut (Lepage et al.,
2008; Zuo et al., 2019). Enrichment of gut phages appears to be
specific to the UC disease state, as healthy controls showed an
enrichment of eukaryotic viruses (Zuo et al., 2019).
Gogokhia et al. (2019) found that intestinal Caudovirales
correlated with the success of FMTs in humans with UC. UC
patients that responded well to FMT had a lower abundance of
Caudovirales before FMT than after treatment, suggesting that
the intestinal phage community could worsen disease (Gogokhia
et al., 2019). This has implications for the potential use of FMT
therapy and clinicians should consider the impact of phages on
patient outcomes.
Comparing phage populations of CD and UC patients shows
a significant difference in the composition of the gut virome,
suggesting that even within IBD the phageome can be influenced
by environmental changes specific to each disease (Norman
et al., 2015). Taken together, this evidence suggests that phages
play a role in IBD, particularly within UC and CD. However, the
difficulty in moving from correlation to causation in the disease
pathology warrants further research into the role of phages as
drivers of human diseases.
Diabetes
Diabetes is a group of diseases characterised by hyperglycemia,
caused by a defect in the action of insulin, the secretion of
insulin, or a combination of both (American Diabetes
Association, 2009). Type 1 diabetes (T1D) is caused by the
autoimmune destruction of pancreatic b-cells, whereas Type 2
diabetes (T2D) is a result of insulin resistance (American
Diabetes Association, 2009). The gut environment has been
associated with the onset of both T1D and T2D, as
environmental factors within the gut are thought to act as
triggers of disease development.June 2021 | Volume 11 | Article 643214
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controls showed that the evenness of two major phage groups,
Myoviridae and Podoviridae, was lower, suggesting that the
distribution of gut phage is disturbed in individuals with T1D
(Zuo et al., 2019). Amyloid-producing E. coli present in the gut
have been linked to the development of autoantibodies
contributing to T1D (Tetz et al., 2019). Diversity of intestinal
E. coli phages was found to be significantly higher in T1D
patients than in control individuals, with almost all the
identified E. coli phages being lysogenic (Tetz et al., 2019). The
ratio of phages to E. coli was also shown to increase in those with
T1D, suggesting continual induction of prophages, or E. coli
harbouring prophages may have a fitness advantage in T1D (Tetz
et al., 2019). Bacteroides dorei has also been found at higher
abundance in individuals with T1D and those at risk of
developing islet autoimmunity (Leonard et al., 2014). There are
a number of methylase genes present in the genomes of B. dorei
temperate phages, which raises questions about the impact of
methylation and prophages on the development of islet
autoimmunity (Leonard et al., 2014). In samples from T1D
patients, CrAssphage were shown to correlate with B. dorei,
but no other Bacteroides (Cinek et al., 2017). However, no
significant relationship between the presence of CrAssphage
and the onset of islet autoimmunity was identified (Cinek
et al., 2017).
Compared to healthy control samples, significantly more
phages were present in the gut of individuals with T2D, which
showed an increased abundance of intestinal Podoviridae
predicted to infect Escherichia and Clostridium (Breitbart et al.,
2018). As Clostridium spp. and E. coli have been found to be
present in higher numbers in T2D patients, this could suggest
that these are temperate phages which proliferate alongside their
host bacteria in accordance with the development of T2D (Qin
et al., 2012). T2D patients’ gut phages carried a large number of
genes which could impact the human host (Ma et al., 2018),
suggesting that phages themselves could drive the pathogenesis
of human diseases.
Interestingly it has been demonstrated that fecal virome
transplant (FVT) can alleviate obesity and T2D in a mouse
model, significantly altering both the bacterial and viral
components of the gut microbiota (Rasmussen et al., 2020).
FVT in mice alleviated some effects of a high-fat diet and
normalised blood glucose tolerance, which was not observed in
control mice (Rasmussen et al., 2020). It has also been suggested
that both Caudovirales richness and the overall viral diversity
in donor faeces can influence the outcome of FVT in T2D,
warranting further investigation (Zuo et al., 2018; Park
et al., 2019).
Despite the research to date, the question remains whether
gut phages influence the onset and development of T1D and
T2D, or whether they act as disease biomarkers, revealing the
effects of diabetes on the gut microbiome. The role of temperate
phages in human disease is currently unknown and it is yet to be
discovered if prophages are induced in the gut environment and
drive the development of T1D or T2D, or if prophage induction
is a response to autoimmunity.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 17Human Immunodeficiency Virus (HIV)
HIV is a highly complex disease with wide-ranging systemic
consequences for the patient, even with the use of antiretrovirals.
The interaction of the gut, blood, and immune system
complicates investigation, but it appears that phages may
predict disease progression and influence responses to therapy.
HIV infections lead to a depletion in CD4+ T cells, rendering the
body vulnerable to infection and disease. The advanced stages of
HIV infection are referred to as acquired immunodeficiency
syndrome (AIDS), a life-threatening condition associated with
excess mortality.
HIV infections initially begin in the gut, with the virus
infecting the intestinal-associated lymphoid tissue (Dillon
et al., 2016). Research over recent years has questioned the role
of the intestinal microbiota in HIV infections, given that these
infections are associated with translocation of the microbiota and
its products across the damaged intestinal epithelial layer
(Brenchley et al., 2006; Klase et al., 2015). The mechanisms by
which HIV alters the gut microbiota and how the microbial
population of the gut modulates differential responses to
infection have previously been reviewed in detail (Dinh et al.,
2015; Zilberman-Schapira et al., 2016).
Comparisons of the microbiota of HIV-infected individuals,
those receiving antiretroviral treatment, or with varying CD4+ T
cell levels found no significant difference in phage richness or
diversity (Monaco et al., 2016). In contrast, other studies have
observed a significant increase in the number of phage sequences
in Simian immunodeficiency virus (SIV)-infected rhesus
monkeys, a commonly used animal model of HIV (Handley
et al., 2012). As phages have been shown to directly interact with
and modulate immune cells, the contribution of phages to HIV
infection should be investigated further (Foca et al., 2015).
The plasma of HIV/AIDS patients was dominated by phages
and bacteria similar to those found in the human gut, whereas
healthy controls showed no detectable phages in their plasma
virome (Li et al., 2012). A high proportion of this HIV-associated
plasma virome was composed of Enterobacteria and Pseudomonas
phages (Li et al., 2012). This could suggest that phages and
bacteria leak from the gut during HIV infection and move into
systemic tissues.
The antiretroviral treatment for HIV could potentially have
unintended effects on the phageome. An increase in gut dysbiosis
has been reported upon administration of antiretroviral therapy,
indicating possible consequences for gut bacteria and their
phages (Klase et al., 2015). If the gut phage populations differ
in HIV-infected individuals, this could have implications for
their response to therapy. The ability of phages to influence the
leaky gut (Li et al., 2012) must also be considered, as it has been
shown that HIV patients with increased gut permeability may
not respond to antiretroviral therapy (Marchetti et al., 2008).
Cardiovascular Disease (CVD)
CVD is a broad term used to define several diseases affecting the
cardiovascular system, including ischaemic heart disease,
myocardial infarction, and congestive cardiac failure. The
driving forces behind the development of CVD areJune 2021 | Volume 11 | Article 643214
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intricately related. Atherosclerosis is an inflammatory response
characterised by macrophage activation and Th1 responses,
among many other contributing factors. The aetiology of CVD
can be bacterial, with direct links between the bacterial
metabolites and risk of atherosclerotic cardiovascular disease
(Wang et al., 2011).
Changes in the gut phageome are more common in patients
with CVD and hypertension (Jie et al., 2017; Han et al., 2018).
The presence of chronic inflammation is a driver of
atherosclerosis and is seen in many autoimmune diseases
(Yarur et al., 2011; Escarcega et al., 2018), and some phages
may have a contributory effect. Phages can induce the production
of IFN-g, a key cytokine in macrophage activation. An increase in
serum phage load was demonstrated in patients with CVD which
potentially plays a role in the driving inflammatory response of
the disease (Dinakaran et al., 2014). Oral administration of phage
cocktails has been shown to increase gut permeability (Tetz et al.,
2017). Subsequently, gut permeability can lead to increased
bacteria and bacteriophages in the bloodstream, with potential
synergistic effects in congestive cardiac failure (Sandek et al.,
2007). To complicate this effect, different phage cocktails induce
varying cytokine profile alterations. Oral administration of T7
phages increased serum cytokines such as IL-1a, IL-1b IL-2, IL-
12 and IL-17 (Park et al., 2014). However, the role of such
cytokines in cardiovascular disease is controversial with evidence
of both pro- and anti-atherosclerotic effects (Gong et al., 2015;
Williams et al., 2019). Therefore, the role of phages in the
development of cardiovascular disease may be due to
modulatory effects on the inflammatory response.
Conversely, there is evidence that phages may have a
protective role against CVD. Swinepox virus (a eukaryotic
virus) has been shown to reduce the incidence of restenosis
following stent insertion, a common treatment option for
patients with angina pectoris and myocardial infarction
(Shimamura et al., 2012). If this is true of eukaryotic viruses,
there are potentially similar effects with bacteriophages also.
Phage as medical tools, such as phage display, can be utilised
for CVD diagnostics (Park et al., 2010) and drug delivery (Nicol
et al., 2009). Phage therapy can be used to prevent or treat post-
heart surgery infections (Potapov et al., 2020), as well as altering
the detrimental metabolism of bacteria in high-risk patients.
As CVD is complex in its aetiology, it is difficult to define the
specific role phages may play in the disease. However, it seems
clear that phage communities vary between healthy and CVD
populations, in addition to their immunomodulatory role,
suggesting this area is worthy of further investigation.
Autism Spectrum Disorder (ASD)
ASD is a developmental disorder characterised by significant
variation in social, communication and behavioural traits. Gut
microbiota changes have been observed in patients with ASD,
typified by reduced biodiversity and changes in gut anaerobic
bacteria abundance, potentially contributing to the disorder’s
severity (Parracho et al., 2005; Krajmalnik-Brown et al., 2015).
An alteration in gut permeability is a hypothesis for the
development of several diseases, including ASD, and the effectsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 18of phages on the gut microbiome may provide a mechanism for
this (Tetz and Tetz, 2016). A trail of a modified FMT treatment
showed gut bacterial populations of individuals with ASD
became more similar to healthy populations, whereas phage
populations remained more diverse; these changes were linked
with an improvement in ASD symptoms (Kang et al., 2017). The
gut phageome is known to change through childhood (see
section Development of the Phageome) (Figure 3), and it is
possible that gut dysbiosis during childhood may contribute to
the development or severity of ASD, as well as several other
psychiatric disorders (Lim et al., 2016; Sherwin et al., 2016;
Dickerson et al., 2017). For example, Lactobacillus phage jadh
has been found to be more common in the oropharyngeal
microbiome in patients with schizophrenia (Sherwin et al., 2016).
Psychiatric disorders are extremely complex, with the direct
causes remaining unknown. From current evidence it appears
that phages, as part of the larger gut microbiome community, are
likely to play a role at some level, which may become clearer with
future research.
Does the Phageome Play a Role in
Human Gut Health?
An increase in the abundance of gut phages appears to be a
common theme across the diseases reviewed here (Table 6).
There is a general shift in the phageome in CD and UC to an
increased number of Caudovirales, with an expansion of a few
particular phage species (Lepage et al., 2008; Wagner et al., 2013;
Norman et al., 2015; Fernandes et al., 2019; Zuo et al., 2019).
However, studies of the phageome in other human diseases
supported evidence that an increase in specific phage species
correlated with disease (Li et al., 2012; Breitbart et al., 2018;
Tetz et al., 2019). This could suggest that the role of phages in
human disease may be specific to particular gut phage-host
relationships, rather than an overall trend within the entire gut
phage community.
Another common theme is a strong association with
dysregulated inflammation underlying disease, which
potentially could elicit phageome’s influence on human disease.
Phage proteins can directly induce gut inflammation (Norman
et al., 2014; Majewska et al., 2015; Miernikiewicz et al., 2016), but
whether this is a response to changes in the gut microbiome, or a
driving factor of gut dysbiosis, is yet to be determined.
Bacterial communities of the gut are the most studied for their
impact on human health and disease, recent research has further
highlighted other populations in the gut communities, including
fungal (Nash et al., 2017) and archaeal communities (Dridi et al.,
2011). Research into the phageome, to date, has aimed to
understand fluctuations in the abundance and diversity of
phage groups, and how these may correlate with disease.
However, we are yet to identify any specific functional
relationships between phages and human disease. Moving
forward, research into the mechanisms by which the gut
phageome influences disease is necessary and may help answer
a number of vital questions. Are specific phage species involved
in causing certain health conditions, or is disease influenced by
the dynamics of the phageome as a whole? What precise
biological mechanisms are behind phage immunomodulation?June 2021 | Volume 11 | Article 643214
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the individual phageome a result of changing gut bacterial
populations? The conditions discussed in this review are
complex and are often associated with individual genetics
combined with environmental triggers; how does the impact
of the phageome vary between individuals in the context of
disease? Resolving these questions will provide a clearer view
of the functional relationship between the phageome and
human disease.
Research so far has presented data on how both phage and
bacterial populations change in comparison to healthy controls.
While this has highlighted areas in which these microbial gut
communities influence disease, we are not frequently given a
longitudinal perspective about how these communities change
with progression from a healthy state to diseased. As earlier
stated (see section Impact of Medical Interventions on the
Phageome), there is limited scope for establishing what can be
described as a “core phageome”, compared to our knowledge of
gut bacterial populations. Variation between individuals is great,
and therefore elucidating if changes in phage populations are due
to a single factor is difficult. Longitudinal studies are becoming
more common, with metagenomic studies of UC and CD
expanding, which may help to define a core phageome and
establish biomarkers of disease (Norman et al., 2015; Manrique
et al., 2016; Clooney et al., 2019). However the chicken-or-egg
argument remains; which came first, the changes in the
microbiome or did the microbiome adapt to the disease? The
phageome adds another layer of complexity to this discussion,
did the phageome, bacterial host or human disease initiate these
changes? By using model systems such as mouse studies, we may
be able to more easily manipulate these factors to unpick the true
workings of the gut phageome. However, reducing gut phageome
studies to these less complex systems eliminates the influence of
the multifaceted human life and cannot be fully reflective of the
true workings of the phageome.
Despite the microbiome receiving much more in-depth
research than the phaegome, limited applications to prevent or
treat diseases exist (Durack and Lynch, 2019). Therefore, it is
likely to be a long time before any therapeutic options for curing
systemic disease by altering the phageome become available.
Perhaps understanding any perturbations of the phageome and
microbiome following the application of a medical treatments,
such as phage therapy, would provide insight into potential new
therapies focussed on the phageome.CONCLUSIONS
In this paper we have shown there is a wealth of literature on the
role of bacteriophages within the human gut. However, there are
still large areas which remain unknown or complex, which with
further investigation could lead to discoveries that inform
beneficial treatments for human disease, in a similar fashion as
we have seen with the microbiome.
The methods used to study phages influence the communities
detected. With recent advances in technology studying in-depthFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 19metagenomes, it is becoming easier to elucidate how these viral
populations change and are influenced by their environment. A
prominent example of these new discoveries are CrAssphage,
recent work has highlighted its existence as an important
component of the human gut phageome. These are just one
group out of many phages in the diverse populations of
microorganisms that colonize our gastrointestinal tract from birth.
We are discovering that phage populations are highly specific
to individuals and the existence of a core phageome, like the
microbiome, is a loose term. Phages perform a number of
functions in the human gut including: genetic exchange,
maintenance of diversity, supply of nutrients and interactions
with the immune system. Additionally, host and virus dynamics
are highly complex and vary depending on the context in which
predator and prey or symbionts meet. Although an understudied
area, it does appear that phage populations vary between healthy
individuals and disease states. It is well understood that the
micro- and mycobiomes influence a variety of human
conditions; this also applies to the phageome. Further research
is warranted to establish if phage manipulation would be
beneficial in these conditions.
From the evidence discussed in this paper, we believe that the
role and impact of the phageome is underexplored, and with
continued investigation potential therapies and a deeper
understanding of the viral influence on human health can
be discovered.
Perspectives and Future Directions
Since the importance of the gut microbiome has come to light
over the past decade, we have increased our understanding of the
function of the human body and how it is not solely “human”.
The reliance we have on microbial communities for even our
basic biology has become abundantly clear. However, as
discussed throughout this paper, the largely overlooked
phageome evidently plays a major role.
We hope that with the continuing improvements in the
availability and accessibility to genomic research methods, the
workings of the phageome will be increasingly understood as we
have seen with the microbiome. As discussed in this paper, DNA
technologies are often utilised, but RNA techniques are still
lacking. Unfortunately this leaves a portion of the phageome
without proper characterisation.
Discovering how these communities interact and interplay
with their human host may lead to improvements in health,
nutrition and wellbeing through manipulation of these
microscopic communities. We believe this is of heightened
importance in light of increasing antimicrobial resistance as
traditional antibiotic therapies may become redundant.
Phage therapy has already been established as a viable
alternative treatment and has found a recent resurgence in
popularity in Western medicine. We hope this therapy
could be applied in complex diseases such as those discussed in
this paper, in which the gut microbiota is disturbed.
Understanding more about the phageome will in turn further
our knowledge of human health, leading to a brighter future for
human health.June 2021 | Volume 11 | Article 643214
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